GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Liabilities-to-Assets

Oxygenta Pharmaceutical (BOM:524636) Liabilities-to-Assets : 1.32 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Oxygenta Pharmaceutical's Total Liabilities for the quarter that ended in Mar. 2024 was ₹833.1 Mil. Oxygenta Pharmaceutical's Total Assets for the quarter that ended in Mar. 2024 was ₹631.9 Mil. Therefore, Oxygenta Pharmaceutical's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 was 1.32.


Oxygenta Pharmaceutical Liabilities-to-Assets Historical Data

The historical data trend for Oxygenta Pharmaceutical's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Liabilities-to-Assets Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.20 2.12 2.11 1.85 1.32

Oxygenta Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 - 1.38 - 1.32

Competitive Comparison of Oxygenta Pharmaceutical's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Liabilities-to-Assets falls into.



Oxygenta Pharmaceutical Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Oxygenta Pharmaceutical's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Liabilities-to-Assets (A: Mar. 2024 )=Total Liabilities/Total Assets
=833.145/631.921
=1.32

Oxygenta Pharmaceutical's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2024 is calculated as

Liabilities-to-Assets (Q: Mar. 2024 )=Total Liabilities/Total Assets
=833.145/631.921
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxygenta Pharmaceutical  (BOM:524636) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Oxygenta Pharmaceutical Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxygenta Pharmaceutical (BOM:524636) Business Description

Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines